BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 325,795 Value ($000) $2,473 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 138,304 Value ($000) $1,239 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 54,022 Value ($000) $405 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 56,644 Value ($000) $426 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 79,468 Value ($000) $604 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 94,467 Value ($000) $584 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 12,499 Value ($000) $63 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 70,091 Value ($000) $420 Avg Close $5.79 Range $4.83 - $7.06